Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs.

Sruamsiri, Rosarin; Kameda, Hideto; Mahlich, Jörg.
Drugs Real World Outcomes; 5(3): 169-179, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30073580